DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Senores Pharmaceuticals Limited — Press Release

NSE 1 hr ago·27 Jul 2026, 10:14 am

Senores Pharmaceuticals

Senores Pharmaceuticals Limited has announced a media release dated July 27, 2026, to the stock exchange. The company has not yet disclosed the specific content of this communication to the public.

This news is significant for investors as it signals an upcoming corporate development. The absence of details means the market is currently awaiting further information to gauge the potential impact on the company's operations or financial outlook.

Investors should monitor the company's official filings for the full text of the release. Keeping an eye on market reaction will be key to understanding the market's interpretation of this development.